June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
The role of the RNA-binding protein Elavl1 in lens development
Author Affiliations & Notes
  • Sarah Coomson
    Department of Biological Sciences, University of Delaware, Newark, Delaware, United States
  • Sandeep Aryal
    Department of Biological Sciences, University of Delaware, Newark, Delaware, United States
  • Salil Anil Lachke
    Department of Biological Sciences, University of Delaware, Newark, Delaware, United States
    Center for Bioinformatics and Computational Biology, University of Delaware, Newark, Delaware, United States
  • Footnotes
    Commercial Relationships   Sarah Coomson None; Sandeep Aryal None; Salil Lachke None
  • Footnotes
    Support  NIH/NEI R01 EY021505
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 652 – F0007. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sarah Coomson, Sandeep Aryal, Salil Anil Lachke; The role of the RNA-binding protein Elavl1 in lens development. Invest. Ophthalmol. Vis. Sci. 2022;63(7):652 – F0007.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Analogous to DNA-binding proteins called transcription factors (TFs) that bind DNA and mediate transcriptional control, RNA-binding proteins (RBPs) bind RNA and control its post-transcriptional fate, such as splicing, transport, localization, stability and translation into protein. While there are more genes in the human genome that encode RBPs compared to DNA-binding proteins, the former class of proteins are grossly less studied compared to the latter, especially in the context of eye development. To address this knowledge-gap, efforts over the past decade have identified several RBPs (e.g. Caprin2, Celf1, Rbm24, Tdrd7, among others) that are required for proper lens development and whose deficiency causes lens defects and/or cataracts (Lachke (2022) PMID: 34906599). To further advance the role of RBPs in the lens, we used iSyTE to identify Elavl1 (ELAV (embryonic lethal, abnormal vision)-like 1; also called HuR (Hu antigen R) as a high-priority candidate and analyzed its relevance to lens development.

Methods : Elavl1 expression in mouse lens was analyzed by RT-PCR, Western Blotting and immunofluorescence staining (IF). Elavl1 lens-specific conditional knockout (Elavl1cKO) mice were generated by crossing mice containing Elavl1 floxed alleles and the Pax6GFPCre mouse line. RNA-IP (RIP) using Elavl1 antibody was performed on wild-type post-natal day (P) 15 mouse lens lysates Elavl1.

Results : Using the systems-based tool for eye gene discovery, iSyTE, we predicted Elavl1 to be robustly expressed in the lens. RT-PCR, WB and IF independently validated Elavl1 expression in embryonic and postnatal lens. Further, Elavl1 protein was detected in both anterior epithelium of the lens and fiber cells. Elavl1cKO mice exhibit microphthalmia and/or lens defects and cataract that progress with age. Initial studies suggest that several lens markers are misexpressed in the Elavl1cKO lens. Further, RIP assays demonstrate that Elavl1 protein binds Pax6 and Prox1 mRNA in lens cells. These findings suggest that Elavl1 may be involved in post-transcriptionally controling these TFs in the lens.

Conclusions : These data demonstrate that Elavl1 is robustly expressed on both RNA and protein levels in lens development. Elavl1 binds to mRNAs encoding key TFs in the lens and its knockout in mice results in eye and lens defects. Together, these findings indicate that Elavl1 plays an important role the development and maintenance of the lens.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×